Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating...
Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating...
Clearmind Medicine股票上涨，因公司宣布已经获得美国一家临床研究机构审批，用于其在美国进行的I/IIa期临床试验A部分治疗...
Clearmind Medicine Shares Are Trading Higher After the Company Announced It Has Received Institutional Review Board Approval From One of Its Clinical Sites in the U.S. for Part A of Its Phase I/IIa Clinical Trial in the United States for Treating Patients Suffering From Alcohol Use Disorder.
Clearmind Medicine股票交易上涨，公司宣布已经获得美国一家临床试验点的机构审查委员会批准，用于治疗酒精滥用障碍患者的I/IIa期临床试验A部分。
资讯热榜
更新时间